Search

The Southwest Foundation for Biomedical Research (SFBR) chimpanzee colony is a conventionally housed production and research population. The present population is 203 chimpanzees, consisting of 87 males and 116 females. Fifty-four apes were born between 1985 and 1989, 56 from 1980 to 1985, 49 from 1975 to 1980, 24 from 1965 to 1975, and 20 from 1954 to 1965. Twenty-five apes were added to the colony from outside sources over the last 10 years. The average yearly mortality for the past 8 years was 2.4%. The primary causes of death since 1982 were heart disease (6), trauma (5), and respiratory disease (4). The heart lesions included myocarditis, necrosis, fibrosis, and mineralization. The respiratory disease deaths were due to Streptococcus pneumoniae and Klebsiella pneumoniae. The traumatic deaths were primarily in young chimpanzees and were caused by adults. Since 1976, 20 stillbirths occurred and were not included in the total deaths. There were two cases of placenta previa and one of abruptio placentae. Clinical conditions not leading to death included respiratory disease, parasitism, alopecia, diarrhea, maternal rejection, and trauma. The most significant commonly isolated bacteria were Staphylococcus, Streptococcus, Haemophilus, Klebsiella, Citrobacter, and Campylobacter. The most common intestinal parasites were Balantidium, Entamoeba, Chilomastix, Iodamoeba, Giardia, Trichuris, Enterobius, and Strongyloides. The colony pathology is sketchy from 1967 to 1981, but the main causes of death during this period were probably pneumonia and intestinal disease. [ABSTRACT FROM AUTHOR]

Leo Fabian played a role in many anesthesia firsts: the first halothane anesthetics in the United States, the first American electrical anesthetic, the first lung allotransplant, and the first heart xenotransplant. As was common for men of his generation, Fabian's first taste of medicine came during World War II, as a pharmacist's mate aboard the U.S.S. Bountiful. Afterward, he pursued his medical education before joining Dr. C. Ronald Stephen and the anesthesiology department at Duke. There he helped to create one of the first inhalers for halothane, the Fabian Newton Stephen (F-N-S) Fluothane Vaporizer. Fabian left Duke for the University of Mississippi Medical Center, where he consistently worked with the chair of surgery, Dr. James Hardy. Together they performed the first American electrical anesthetic, the first lung allotransplant, and the first heart xenotransplant. By the end of his time at Mississippi, Fabian and Hardy had several philosophical disagreements, and Fabian ultimately left for Washington University in St. Louis, where he rejoined Dr. Stephen. He served as Stephen's right-hand man and would oversee the department when Stephen was away. Fabian spent the final years of his career as chair of the department before his own health forced him to step down., (Copyright © 2019 Anesthesia History Association. Published by Elsevier Inc. All rights reserved.)

Chimpanzees demand specialized housing and care and the highest degree of attention to animal welfare. The current project used a survey method to collate information on chimpanzee housing and behavioral indices of welfare across all 6 of the chimpanzee research facilities in the United States. Data were compiled on 701 chimpanzees ranging from 2 to 62 y old (mean age, 26.0 y). All chimpanzees except for one were socially housed; the median group size was 7 animals, and group sizes ranged from 1 to 14. All of the subjects had access to outdoor spaces each day. Daily access to a natural substrate in the chimpanzee's enclosure was available for 63.8% of the subjects. Overall, 94.1% of the chimpanzees used tools to acquire food, 48.1% built nests, 75.8% copulated, and 83.3% initiated grooming bouts. The following atypical behaviors were reported most often: rocking (13.0%), coprophagy (10.0%), and stereotyped behaviors other than rocking (9.4%). There was widespread evi- dence of positive animal training techniques, with nearly all (97.7%) subjects reported to generally voluntarily cooperate with shifting in their enclosure, and 72.2% were reported to present for an injection of anesthetic. We include some comparison between these findings and data describing zoo-housed chimpanzees. In addition, we discuss survey findings in reference to recommendations made by the NIH Working Group on the Use of Chimpanzees in NIH-supported Research. The current survey assessed a larger sample of chimpanzees living under human care than has been published previously. This broad analysis can help to guide future improvements in behavioral management to address behavioral problems or deficits.

The unprecedented recent decision-making about chimpanzees supported for biomedical science by the US National Institutes of Health attracted international attention and significantly changed many dimensions of chimpanzee research. Many public and media portrayals incorrectly generalized the NIH findings to conclude that chimpanzee research itself was no longer necessary. In fact, the broader question of the necessity and value of the full range of chimpanzee research was never asked, evaluated, or within the NIH's primary charge. The Institute of Medicine evaluative panel found that research with chimpanzees was necessary for some, but not all, purposes. The panel's findings also led the NIH to introduce new standards for the care and management of NIH-supported chimpanzees and a new mechanism for ethical review of grant proposals involving chimpanzees. The NIH evaluation and decisions could not address all captive chimpanzees and all types of research. However, the process did underscore the need for a more expansive framework for continued ethical review and decision-making to responsibly address the future of captive chimpanzee management and research. Among the broader considerations are extension of evidence-informed standards to ensure equitable care and treatment of all chimpanzees; determining the global impact of limited captive populations; and balancing benefit and harm at individual, species, societal, and environmental levels. The breadth and longevity of impact from the current US decisions suggest the need for many voices, disciplines, and stakeholders to address the complex interplay between science, animal welfare, and global health., (© 2015 Wiley Periodicals, Inc.)

We argue that the recommendations made by the Institute of Medicine's 2011 report, Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity, are methodologically and ethically confused. We argue that a proper understanding of evolution and complexity theory in terms of the science and ethics of using chimpanzees in biomedical research would have had led the committee to recommend not merely limiting but eliminating the use of chimpanzees in biomedical research. Specifically, we argue that a proper understanding of the difference between the gross level of examination of species and examinations on finer levels can shed light on important methodological and ethical inconsistencies leading to ignorance of potentially unethical practices and policies regarding the use of animals in scientific research.

A common assumption in the selection of nonhuman animal subjects for research and the approval of research is that, if the risks of a procedure are too great for humans, and if there is a so-called scientific necessity, then it is permissible to use nonhuman animal subjects. I reject the common assumption as neglecting the central ethical issue of the permissibility of using nonhuman animal subjects and as being inconsistent with the principle of justice used in human subjects research ethics. This principle requires that certain classes of individuals not be subjected to a disproportionate share of the burdens or risks of research. I argue for an extension of this principle to nonhuman animal research and show that a prima facie violation of the principle occurs because nonhuman animals bear an overwhelmingly disproportionate share of the risks of research without sufficient justification or reciprocal benefit.

The Institute of Medicine (IOM) Committee on the Necessity of the Use of Chimpanzees in Biomedical and Behavioral Research made a series of recommendations that, as of an announcement on June 26, 2013, the National Institutes of Health (NIH) is turning into implemented guidelines. Many advocates, including some researchers and scholars, have suggested that the Committee's recommendations could be applied successfully to other animal species. This article examines, from my perspective as the IOM Committee's chair, some of the most important features of the Committee's work, addresses whether chimpanzees represent a special or unique case for the purpose of research policy, and suggests an approach for evaluating the applicability of the Committee's recommendations for other animal species used in research. I first present my perspective on the features of the Committee's work that influenced its approach and conclusions. I then argue that despite the fact that chimpanzees represent a somewhat unique case for restricted research use, their case still offers important lessons for policy regarding the use of other species. Finally, I offer some observations regarding the recommendations and implications of the report from the NIH Working Group charged with crafting guidelines for implementing the IOM Committee's recommendations.

Literature on the mental capacities and cognitive mechanisms of the great apes has been silent about whether they can act autonomously. This paper provides a philosophical theory of autonomy supported by psychological studies of the cognitive mechanisms that underlie chimpanzee behavior to argue that chimpanzees can act autonomously even though their psychological mechanisms differ from those of humans. Chimpanzees satisfy the two basic conditions of autonomy: (1) liberty (the absence of controlling influences) and (2) agency (self-initiated intentional action), each of which is specified here in terms of conditions of understanding, intention, and self-control. In this account, chimpanzees make knowledge-based choices reflecting a richly information-based and socially sophisticated understanding of the world. Finally, two major theories of autonomy (Kantian theory and two-level theory) are rejected as too narrow to adequately address these issues, necessitating the modifications made in the present approach.

Recent theoretical and experimental investigations of altruistic behavior in intergroup conflict in humans frequently make use of the assumption that warfare can be modeled as a symmetrical n-person prisoner's dilemma, abstracting away the strategic differences between attack and defense. In contrast, some empirical studies on intergroup conflict in hunter-gatherer societies and chimpanzees indicate that fitness relevant risks and potential benefits of attacks and defenses might have differed substantially under ancestral conditions. Drawing on these studies, it is hypothesized that the success of defenses was much more important for individual and kin survival and that a disposition to act altruistically during intergroup conflict is thus more likely to evolve for the strategic situation of defense. It is then investigated empirically if such asymmetries in the occurrence of altruistic behavior during intergroup conflict can be found. Analyzing detailed historical case data from 20th century wars, this study finds that altruistic behavior towards members of the in-group indeed seems to occur more frequently when soldiers are defending themselves and their comrades against enemy attacks. It is proposed that this asymmetry reflects adaptive behavioral responses to the materially different strategic character of attacks and defenses under ancestral conditions. If true, this would call for a refinement of theories of the evolutionary interaction of intergroup conflict and altruism.

The aim of this essay is to show that there are no easy options for those who are disturbed by the suggestion that infanticide may on occasion be morally permissible. The belief that infanticide is always wrong is doubtfully compatible with a range of widely shared moral beliefs that underlie various commonly accepted practices. Any set of beliefs about the morality of abortion, infanticide and the killing of animals that is internally consistent and even minimally credible will therefore unavoidably contain some beliefs that are counterintuitive.

Approximately 1000 chimpanzees are currently held in five federally owned, or supported, US laboratories. This study reviews 110 autopsy reports on chimpanzees who died from 2001-2011 in laboratories or in sanctuaries (but who were from laboratories), in order to glean information about their premorbid health and causes of death. The findings raise questions about the health status of the chimpanzees remaining in laboratories. Most of the chimpanzees currently held are not involved in active protocols. The Chimpanzee Health Improvement, Maintenance, and Protection (CHIMP) Act 2000 states that chimpanzees "not needed" for research "shall" be accepted into the federal sanctuary system, but criteria for when a chimpanzee is deemed "not needed" are not given. The assessment of "not needed" lies with the Secretary of Health and Human Services, who has left the decision to the discretion of the laboratories. This autopsy review revealed that the majority of the chimpanzees who died in laboratories had been suffering from significant chronic or incurable illnesses, and most often had multi-system diseases that should have made them ineligible for future research, on scientific, as well as ethical, grounds. The study's findings are significant in establishing the need for defined criteria for chimpanzee retirement to sanctuary., (2012 FRAME.)

Serial plasma aliquots (50 mL) obtained from 10 commercial donors who converted from hepatitis C virus (HCV) RNA negative to positive were transfused into 2 chimpanzees to assess infectivity during early HCV infection. Plasma, obtained 4 days before HCV RNA detectability by licensed assays, transmitted HCV infection to chimpanzee X355. The infectious PCR-negative plasma was subsequently shown to be positive in 2 of 23 replicates using a sensitive transcription-mediated amplification (TMA) assay, and estimated to contain 1.2 HCV RNA copies/mL (60 copies/50 mL transfused). Plasma units obtained up to 8 weeks earlier were not infectious in a second susceptible chimp, even when from donors with low-level, intermittent HCV RNA detection. Chimp x355 developed acute viremia with subsequent seroconversion, but cleared both virus and Ab in 17 weeks. When rechallenged 38 months later with 6000 RNA copies/mL from the same donor, X355 was transiently reinfected and again rapidly lost all HCV markers. We conclude that: (1) transfusions can transmit HCV infection before RNA detection, but the interval of test-negative infectivity is very brief; (2) early "blips" of HCV RNA appear noninfectious and can be ignored when calculating residual transfusion risk; and (3) markers of HCV infection can be lost rapidly after exposure to low-dose inocula.

Leprosy is a chronic infectious disorder caused by Mycobacterium leprae, which mainly affects skin and peripheral nerves. It is classified as either paucibacillary or multibacillary based upon clinical manifestations and slit-skin smear results. It is speculated that leprosy develops after a long latency period following M. leprae infection. However, the actual time of infection and the duration of latency have never been proven in human patients. To date, four cases of spontaneous leprosy have been reported in chimpanzees who were caught in West Africa in infancy and used for medical research in the USA and Japan. One of these chimpanzees was extensively studied in Japan, and single-nucleotide polymorphism analysis for the M. leprae genome was conducted. This analysis revealed that the chimpanzee was infected with M. leprae during infancy in West Africa and the pathognomonic signs of leprosy appeared after at least 30 years of incubation. Analysis of leprosy in chimpanzees can contribute not only to medical research but also to the understanding of the pathoetiology of leprosy.

Dengue is a mosquito-borne viral disease of humans that has re-emerged in many parts of the world and has become an important international public health threat. Dengue incidence and geographical spread has dramatically increased in the last few decades and is now affecting most tropical and sub-tropical regions of the world. Despite extensive research efforts for several decades, no vaccines or therapeutics are currently available to prevent and treat dengue infections. One of the main obstacles to the development of countermeasures has been the lack of good animal models that recapitulate dengue pathogenesis in humans and reliably predict the safety and efficacy of countermeasures against dengue. In September 2008, the National Institute of Allergy and Infectious Diseases (NIAID) held a workshop to consider the current state-of-the-art developments in animal models for dengue and discuss strategies to accelerate progress in this field. This report summarizes the main discussions and recommendations that resulted from the meeting., ((c) 2010. Published by Elsevier Ltd.. All rights reserved.)